Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-09-04 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
七届董事会2018年第七次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by 中粮生物化学（安徽）股份有限公司. It details the attendance, voting results, and the approval of an investment proposal to establish a wholly-owned subsidiary. There is no financial data, earnings information, or detailed report content. The document is an announcement of board decisions, specifically about management-level decisions and company investments. This fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but a formal announcement of board resolutions.
2018-09-04 Chinese
关于投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 中粮生物化学（安徽）股份有限公司 regarding the investment to establish a wholly-owned subsidiary. It details the investment amount, board approval, company information, and the purpose and risks of the investment. There are no financial statements or detailed financial performance data. The document is a formal announcement about a capital investment and company structure change, not a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through establishing a new subsidiary.
2018-09-04 Chinese
关于收到徽商银行2017年度股票股利及现金股利的自愿性信息披露公告
Notice of Dividend Amount Classification · 95% confidence The document is a voluntary disclosure announcement regarding receipt of stock dividends and cash dividends from a bank's 2017 profit distribution plan. It details the number of shares held, dividend amounts, and receipt dates. There are no financial statements, comprehensive financial data, or detailed analysis. The document is short (653 characters) and serves as an announcement of dividend receipt rather than a full dividend notice or financial report. Therefore, it fits best as a Notice of Dividend Amount (DIV) since it announces dividend amounts and payment details relevant to shareholders.
2018-09-03 Chinese
关于收到《中国证监会行政许可项目审查一次反馈意见通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (790 characters) from a listed company regarding receipt of a regulatory feedback notice from the China Securities Regulatory Commission (CSRC) about an administrative licensing project review related to a share issuance for asset purchase. It states the company will respond in writing within 30 working days and disclose the reply in a future announcement. There is no financial data, no full report, and the document mainly informs about regulatory feedback and next steps. It is not a full report like an Annual Report or Interim Report, nor a call transcript or earnings release. It is an official regulatory announcement about a licensing process and related administrative matters. According to the rules, such regulatory announcements that do not fit other categories are best classified as Regulatory Filings (RNS).
2018-08-30 Chinese
关于公司七届董事会2018年第六次临时会议决议公告的更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding a previous board meeting resolution about financing matters. It specifically corrects details about credit and financing applications to banks. The document is short (1242 characters) and serves to amend a prior announcement rather than presenting new financial data or a full report. It does not contain financial statements or detailed financial analysis. It is an announcement related to board decisions on financing but is not a full Capital/Financing Update report. Given the nature of the document as a correction to a prior announcement, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2018-08-29 Chinese
七届监事会2018年第二次临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the Supervisory Board of a company regarding the resolution passed in their second extraordinary meeting in 2018. It specifically mentions the review and approval of the company's 2018 semi-annual report and its summary. The document includes statements about the compliance of the report with regulatory requirements, the accuracy and completeness of the information, and the legal and procedural correctness of the report's preparation and review. However, the document itself does not contain the actual financial statements or detailed financial data of the semi-annual report; it is a resolution announcement about the approval of that report. The document length is short (1101 characters), and it serves as an official announcement of the Supervisory Board's resolution rather than the report itself. According to the classification rules, such announcements about the approval or publication of a report, especially when short and without substantive financial data, should be classified as Regulatory Filings (RNS) rather than as the Interim/Quarterly Report (IR) itself.
2018-08-27 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.